|
FDA Public Workshop
“Testosterone Use in Menopausal Women”
Now Available via YouTube Livestream
FDA Office of Women’s Health (OWH) and the Center for Drug Evaluation and Research (CDER) are pleased to share an update regarding the upcoming FDA public workshop, "Testosterone Use in Menopausal Women."
In response to significant interest in the workshop, the meeting will now be available via YouTube livestream, expanding access to all who wish to participate virtually. We appreciate the strong interest from the public health and scientific communities and look forward to a robust and engaging discussion.
Time: 9:00 AM – 4:30 PM ET
Format: YouTube Livestream
IMPORTANT NOTICE: If you previously received a Zoom link for this meeting, please disregard it. The Zoom link is no longer valid. This meeting will be broadcast exclusively via YouTube Livestream. Please do not attempt to join via Zoom.
In addition to workshop, the FDA has also opened a docket to allow for submission of broad, public comments on the risks and benefits related to testosterone use in menopausal women. The docket will be open for public comments for 60 days. To be assured of consideration, comments must be received no later than 11:59 p.m. Eastern Time (ET) on October 19, 2026. Visit Regulations.gov for complete details on submission requirements for comments.
|
|
|
|
